Reducing candidaemia risk in urology patients: Revised algorithm & Pharmacist-Led Implementation

IF 2.7 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Nicholai De La Cruz , Ann Whitaker , Nicholas Rukin , Kevin O'Callaghan
{"title":"Reducing candidaemia risk in urology patients: Revised algorithm & Pharmacist-Led Implementation","authors":"Nicholai De La Cruz ,&nbsp;Ann Whitaker ,&nbsp;Nicholas Rukin ,&nbsp;Kevin O'Callaghan","doi":"10.1016/j.idh.2024.06.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Candidaemia is an invasive infection with high morbidity and mortality. All urology procedures carry risk of post-operative infection. Risk mitigation strategies include preoperative urine culture and treatment of cultured organism(s) regardless of symptoms. After zero cases of candidaemia for two years, there were five cases in elective urology patients within 15 weeks between June – September 2021. This increased incidence of candidaemia amongst these patients prompted multidisciplinary investigation.</p></div><div><h3>Methods</h3><p>Single centre case series, in a 250-bed hospital which annually performs 2000-2500 elective urology surgeries. Affected patients were elderly with multiple comorbidities. Notably, four of five patients had prior indwelling ureteral stents. All five patients had preoperative bacteriuria requiring antibiotics and one patient had pre-operative candiduria.</p></div><div><h3>Results</h3><p>Hypotheses including sterilisation failure, surgical instrument contamination, or surgical technique issues were unfounded. We propose that pre-operative duration of antibacterial therapy, particularly in the setting of ureteral stent biofilm, is a significant factor for candiduria. A new prescribing algorithm for urology patients was devised. Antibiotic treatment duration in asymptomatic patients with indwelling urinary tract foreign material was reduced from 14 to 3 days, and from 14 to 7 days in symptomatic patients. Dedicated pharmacist resources were allocated to support this change and pre-operatively manage these patients. These interventions led to zero candidaemia cases over the subsequent 21 months, along with zero post-operative bacterial bloodstream infections.</p></div><div><h3>Conclusions</h3><p>Prolonged pre-operative antibacterial therapy poses a risk for post-operative candidaemia, especially in patients with ureteral stents. Shortening pre-operative antibiotic courses, coupled with increased pharmacist involvement, effectively reduced candidaemia incidence.</p></div>","PeriodicalId":45006,"journal":{"name":"Infection Disease & Health","volume":"29 4","pages":"Pages 227-232"},"PeriodicalIF":2.7000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Disease & Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468045124000312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Candidaemia is an invasive infection with high morbidity and mortality. All urology procedures carry risk of post-operative infection. Risk mitigation strategies include preoperative urine culture and treatment of cultured organism(s) regardless of symptoms. After zero cases of candidaemia for two years, there were five cases in elective urology patients within 15 weeks between June – September 2021. This increased incidence of candidaemia amongst these patients prompted multidisciplinary investigation.

Methods

Single centre case series, in a 250-bed hospital which annually performs 2000-2500 elective urology surgeries. Affected patients were elderly with multiple comorbidities. Notably, four of five patients had prior indwelling ureteral stents. All five patients had preoperative bacteriuria requiring antibiotics and one patient had pre-operative candiduria.

Results

Hypotheses including sterilisation failure, surgical instrument contamination, or surgical technique issues were unfounded. We propose that pre-operative duration of antibacterial therapy, particularly in the setting of ureteral stent biofilm, is a significant factor for candiduria. A new prescribing algorithm for urology patients was devised. Antibiotic treatment duration in asymptomatic patients with indwelling urinary tract foreign material was reduced from 14 to 3 days, and from 14 to 7 days in symptomatic patients. Dedicated pharmacist resources were allocated to support this change and pre-operatively manage these patients. These interventions led to zero candidaemia cases over the subsequent 21 months, along with zero post-operative bacterial bloodstream infections.

Conclusions

Prolonged pre-operative antibacterial therapy poses a risk for post-operative candidaemia, especially in patients with ureteral stents. Shortening pre-operative antibiotic courses, coupled with increased pharmacist involvement, effectively reduced candidaemia incidence.

降低泌尿科患者的念珠菌血症风险:修订算法与药剂师主导的实施。
背景:念珠菌病是一种侵袭性感染,发病率和死亡率都很高。所有泌尿外科手术都有术后感染的风险。降低风险的策略包括术前进行尿液培养,并对培养出的病原体进行治疗,而不论其症状如何。念珠菌血症病例在两年内为零,而在 2021 年 6 月至 9 月的 15 周内,泌尿外科择期手术患者中出现了五例念珠菌血症病例。这些患者中念珠菌血症发病率的增加引发了多学科调查:单中心病例系列,在一家拥有 250 张床位的医院进行,该医院每年进行 2000-2500 例泌尿外科择期手术。受影响的患者均为患有多种并发症的老年人。值得注意的是,五名患者中有四名曾使用过留置输尿管支架。五名患者术前均有细菌尿,需要使用抗生素,一名患者术前有念珠菌尿:结果:包括消毒失败、手术器械污染或手术技术问题在内的各种假设均不成立。我们认为,术前抗菌治疗的持续时间,尤其是在输尿管支架生物膜的情况下,是导致念珠菌尿的重要因素。我们为泌尿科患者设计了一种新的处方算法。无症状的留置尿道异物患者的抗生素治疗时间从 14 天缩短至 3 天,有症状的患者则从 14 天缩短至 7 天。药剂师被分配了专门的资源来支持这一变化,并对这些患者进行术前管理。通过这些干预措施,在随后的 21 个月中,念珠菌血症病例为零,术后细菌性血流感染病例为零:结论:长期的术前抗菌治疗会带来术后念珠菌血症的风险,尤其是在使用输尿管支架的患者中。缩短术前抗生素疗程,同时加强药剂师的参与,可有效降低念珠菌血症的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection Disease & Health
Infection Disease & Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
5.70
自引率
5.70%
发文量
40
审稿时长
20 days
期刊介绍: The journal aims to be a platform for the publication and dissemination of knowledge in the area of infection and disease causing infection in humans. The journal is quarterly and publishes research, reviews, concise communications, commentary and other articles concerned with infection and disease affecting the health of an individual, organisation or population. The original and important articles in the journal investigate, report or discuss infection prevention and control; clinical, social, epidemiological or public health aspects of infectious disease; policy and planning for the control of infections; zoonoses; and vaccination related to disease in human health. Infection, Disease & Health provides a platform for the publication and dissemination of original knowledge at the nexus of the areas infection, Disease and health in a One Health context. One Health recognizes that the health of people is connected to the health of animals and the environment. One Health encourages and advances the collaborative efforts of multiple disciplines-working locally, nationally, and globally-to achieve the best health for people, animals, and our environment. This approach is fundamental because 6 out of every 10 infectious diseases in humans are zoonotic, or spread from animals. We would be expected to report or discuss infection prevention and control; clinical, social, epidemiological or public health aspects of infectious disease; policy and planning for the control of infections; zoonosis; and vaccination related to disease in human health. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in this ever-changing field. The audience of the journal includes researchers, clinicians, health workers and public policy professionals concerned with infection, disease and health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信